Prospective analysis of ComparIson of pReventive effect on CardiovascuLar Events with different statin therapy (P-CIRCLE)

Not Applicable

• Conditions: Patients with coronary artery disease who underwent PCI

• Registration Number: JPRN-UMIN000008042
• Lead Sponsor: Kawasaki Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 660

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who met contraindication of LIVALO tablet below - Patients who have hypersensitivity to LIVALO tablet -Patients who have severe liver dysfunction or biliary atresia. -Co-administration with cyclosporine -Women who are pregnant or may become pregnant or nursing mothers 2.Patients who meet contraindication of LIPITOL tablet below - Patients who have hypersensitivity to LIPITOL tablet -Patients with the following diseases considered to be associated with defective hepatic metabolism: acute hepatitis, acute exacerbation of chronic hepatitis, liver cirrhosis, hepatic carcinoma and/or icterus -Women who are pregnant or may become pregnant or nursing mothers 3.Patients with hepatic disorders (ALT or AST level is equal or greater than 100IU/L) 4.Patients who are ineligible in the opinion of the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified